Albany, NY, Jan. 12, 2016 — Transparency Market Research has published a new market report titled “Microbiology Culture Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023”, the global microbiology culture market was valued at US$4.51 bn in 2014 and is anticipated to reach US$7.59 bn by 2023, expanding at a CAGR of 5.9% during the forecast period from 2015 to 2023.
Microbial cultures play a major role as key tools in biological, medical, or biotechnology research. Pharmaceutical microbiology has witnessed major developments in the last decade. The number of tests have increased significantly along with major modifications in terms of testing procedures. With improved GMP facilities being set up globally, microbiological testing of a product, environment, and equipment has become obligatory. Therefore, usage of microbiology consumables, such as culture media, has increased. This has opened new avenues for the microbiology culture market. Switching consumables supplier becomes difficult for established market players due to the need of validated products and procedures for testing.
The market has grown significantly in the last few decades in terms of demand in various end-user industries. Academia, clinical research organizations, and commercial end-user industries such as pharmaceutical, cosmetics, and food and beverage are providing impetus to the global microbiology culture market. The increasing potential of bioprocessing and biopharmaceutical applications has driven demand for microbiology culture media products.
Key factors driving the global microbiology culture market are high demand for improved antibiotics, increasing food microbiology, rising life science research funding, and high prevalence of foodborne and other infectious diseases. Moreover, the microbiology culture market is witnessing strong growth due to rising food safety concerns, increasing number of food recalls, evolving pathogens, growing press coverage and public awareness, and increasing demand in other industries. Additionally, the industry is expected to expand at a rapid rate due to increased food sourcing due to rise in global food demand and supply. This, in turn, would require advanced culture methods and media for fast and accurate microbial analysis. Microbiology culture methods are the principal diagnostic methods used to determine the cause of infectious diseases by culturing the pathogen in a preset medium.
Major key players profiled in the report include Becton, Dickinson and Company, bioMérieux S.A., Bio-Rad Laboratories, Inc., Eiken Chemical Co, Ltd., EMD (Merck) Millipore, Hi-Media Laboratories Pvt. Ltd., Neogen Corporation, Sigma-Aldrich Co. LLC, Scharlab S.L., and Thermo Fisher Scientific, Inc.
The global microbiology culture market is segmented into the following categories:
- Microbiology Culture Market, By Culture Type
- Bacterial Culture
- Eukaryotic Culture
- Microbiology Culture Market, By Media Type
- Simple Media
- Complex Media
- Synthetic Media
- Special Media
- Microbiology Culture Market, By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Rest of the World (RoW)
Other Reports by Transparency Market Research:
E.coli Testing Market: http://www.transparencymarketresearch.com/e-coli-testing-market.html
Agricultural Biotechnology Market:
http://www.transparencymarketresearch.com/agricultural-biotechnology-market.html
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.


RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Britain Courts Anthropic Amid US Defense Department Dispute
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 



